5:32 PM
 | 
Feb 25, 2013
 |  BC Extra  |  Company News

Cubist receives option to acquire Adynxx

Cubist Pharmaceuticals Inc. (NASDAQ:CBST) received an exclusive option to acquire Adynxx Inc. (San Francisco, Calif.) following data from a Phase II trial of...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >